Related Experiment Video

Updated: Apr 26, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.8K

Restoring TRAIL mediated signaling in ovarian cancer cells

Ammad Ahmad Farooqi1, Ilhan Yaylim, Nazlı Ezgi Ozkan

  • 1Laboratory for Translational Oncology and Personalized Medicine, RLMC, 35 km Ferozepur Road, Lahore, Pakistan, Ammadahmad638@yahoo.com.

Archivum Immunologiae Et Therapiae Experimentalis
|July 18, 2014
PubMed

Insights

This review details ovarian cancer's complexity and explores new treatments targeting tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling. Understanding these pathways enhances drug development for better ovarian cancer survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer is a complex disease with genetic and epigenetic alterations.
  • Mechanisms regulating tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis are crucial in ovarian cancer.
  • Recent advancements in characterizing ovarian cancer cells drive new therapeutic strategies.

Purpose of the Study:

  • To review the molecular mechanisms of TRAIL-mediated apoptosis in ovarian cancer.
  • To highlight the development of novel drugs targeting negative regulators of TRAIL signaling.
  • To discuss the role of programmed cell death protein 4, platelet-derived growth factor signaling, and miRNA in TRAIL-mediated apoptosis.

Main Methods:

  • Literature review of in vitro and in vivo studies on ovarian cancer.
  • Analysis of molecular mechanisms regulating TRAIL-mediated apoptosis.
  • Examination of synthetic and natural agents that stimulate death receptor expression.

Main Results:

  • Ovarian cancer cell characterization has accelerated the development of targeted therapies.
  • Various agents can stimulate mRNA and protein expression of death receptors.
  • Mapatumumab and PRO95780 have shown efficacy in ovarian cancer treatment.

Conclusions:

  • Targeting negative regulators of TRAIL signaling offers promising therapeutic avenues for ovarian cancer.
  • High-throughput screening assays can help manage ovarian cancer heterogeneity.
  • Translating molecular and cellular findings to clinical research is key for improving long-term survival in ovarian cancer patients.

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.4K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

20.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K